How much does it cost to treat tucatinib every month? Is it affordable?

Tucatinib (Tucatinib), as an innovative therapy targeting HER2 positive breast cancer, has attracted much attention in the global cancer treatment field in recent years. Since the drug has not yet been officially launched in mainland China, patients cannot purchase it directly through domestic channels, nor can they enjoy medical insurance reimbursement, which undoubtedly increases the financial burden for many patients. However, when the disease progresses rapidly and treatment options are limited, many patients are still willing to bear the cost and choose to purchase drugs overseas.

In terms of price, the original drug of tucatinib (mainly developed by Seagen Company in the United States) is currently priced higher in the European market. Taking 150mg*84 tablets as an example, the price of a box may be as high as more than 40,000 yuan, and it is the amount required for a single monthly treatment. For ordinary families, the monthly cost of tens of thousands of yuan for continued treatment with this drug will pose a heavy pressure. This is also one of the important reasons why most patients stay away from it, especially when it is not covered by medical insurance and the out-of-pocket purchase burden is not small.

However, it is gratifying to know that generic versions of tucatinib are currently available on the market. Take the 150mg*60 tablet product produced by a Lao pharmaceutical factory as an example. Each box sells for about more than 2,000 yuan. This kind of generic drug is basically the same as the original drug in terms of drug ingredients and therapeutic effects, and can provide patients with a more economical alternative, especially suitable for long-term treatment or when it needs to be used in combination with other drugs.

Taken together, if you choose original drugs, the monthly treatment cost may be as high as 40,000 yuan or more; while using Laos generic drugs, the monthly cost is about 3,000 yuan, which greatly lowers the economic threshold. For most patients, if their economic conditions are average, it is recommended to give priority to generic drugs from regular channels under the guidance of a doctor, which can not only ensure the treatment effect, but also reduce family pressure.

Reference materials:https://www.drugs.com/